Zevra Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ZVRA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Sep 25	BuyUS$157,800	Alvin Shih	Individual	20,000	US$7.89
12 Sep 25	BuyUS$24,718	Tamara Favorito	Individual	3,175	US$7.79
19 Aug 25	BuyUS$45,825	John Bode	Individual	5,000	US$9.17
28 Mar 25	BuyUS$2,352	Corey Watton	Individual	300	US$7.84
19 Mar 25	BuyUS$79,624	John Bode	Individual	10,000	US$7.96

Insider Trading Volume

Insider Buying: ZVRA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZVRA?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	61,127	0.109%
Individual Insiders	485,441	0.862%
Hedge Funds	3,476,143	6.17%
General Public	15,509,248	27.5%
Institutions	36,765,576	65.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 57.06% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.17%	BlackRock, Inc.	4,037,154	US$35.2m	-1.09%	no data
6.17%	Woodline Partners LP	3,476,143	US$30.3m	-24.7%	0.14%
5.48%	The Vanguard Group, Inc.	3,083,362	US$26.9m	4.43%	no data
3.95%	Adage Capital Management, L.P.	2,225,000	US$19.4m	-46.6%	0.03%
3.5%	Nantahala Capital Management, LLC	1,971,936	US$17.2m	34%	0.93%
2.9%	FMR LLC	1,634,457	US$14.2m	-28.6%	no data
2.54%	State Street Global Advisors, Inc.	1,427,291	US$12.4m	15%	no data
2.31%	Geode Capital Management, LLC	1,300,340	US$11.3m	4.66%	no data
2.19%	Aigh Capital Management, LLC	1,231,932	US$10.7m	34.1%	3.09%
2.14%	Susquehanna International Group, LLP	1,205,514	US$10.5m	646%	0.01%
1.87%	Legal & General Investment Management Limited	1,053,399	US$9.2m	12.6%	no data
1.84%	Millennium Management LLC	1,035,251	US$9.0m	63.1%	0.01%
1.73%	683 Capital Management, LLC	975,000	US$8.5m	-13.3%	0.73%
1.62%	Marshall Wace LLP	912,299	US$7.9m	0%	0.01%
1.44%	Stonepine Capital Management LLC	810,000	US$7.1m	4.43%	3.11%
1.29%	D. E. Shaw & Co., L.P.	725,830	US$6.3m	283%	0.01%
1.27%	The Goldman Sachs Group, Inc.	714,001	US$6.2m	121%	no data
1.23%	Royce & Associates, LP	691,239	US$6.0m	0%	0.05%
1.15%	Kingdon Capital Management, L.L.C.	650,000	US$5.7m	44.4%	0.86%
1.07%	The Retirement Planning Company of New England, Inc.	600,770	US$5.2m	8.58%	2.05%
0.97%	Morgan Stanley	544,904	US$4.7m	163%	no data
0.91%	Caption Management, LLC	510,091	US$4.4m	0%	0.26%
0.8%	Tudor Investment Corporation	447,896	US$3.9m	0%	0.03%
0.78%	Northern Trust Global Investments	439,480	US$3.8m	3.38%	no data
0.74%	Algert Global LLC	418,550	US$3.6m	0%	0.06%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/07 16:22
End of Day Share Price	2025/12/05 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zevra Therapeutics, Inc. is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sumant Satchidanand Kulkarni	Canaccord Genuity
Dewey Steadman	Canaccord Genuity
Louise Chen	Cantor Fitzgerald & Co.